Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
3(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_1
1
8%
Ph not_applicable
9
75%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(6)
Other(3)

Detailed Status

Completed6
Recruiting3
unknown3

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (9.1%)
Phase 21 (9.1%)
N/A9 (81.8%)

Trials by Status

completed650%
recruiting325%
unknown325%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12